Ustekinumab Treatment and Improvement of Physical Function and Health‐Related Quality of Life in Patients With Psoriatic Arthritis

OBJECTIVE: To examine the effects of ustekinumab on patient‐reported outcomes (PROs) in PSUMMIT 1 and PSUMMIT 2 patients with active psoriatic arthritis (PsA) who were methotrexate (MTX) naive, MTX experienced, or anti–tumor necrosis factor (TNF) experienced. METHODS: Patients in the phase 3, PSUMMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Proton, Puig, Lluis, Gottlieb, Alice B., Kavanaugh, Arthur, McInnes, Iain B., Ritchlin, Christopher, Li, Shu, Wang, Yuhua, Song, Michael, Mendelsohn, Alan, Han, Chenglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132036/
https://www.ncbi.nlm.nih.gov/pubmed/27483458
http://dx.doi.org/10.1002/acr.23000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132036/
https://www.ncbi.nlm.nih.gov/pubmed/27483458
http://dx.doi.org/10.1002/acr.23000

Ejemplares similares